↓ Skip to main content

Optimal step doses for drug provocation tests to prove beta‐lactam hypersensitivity

Overview of attention for article published in Allergy, November 2016

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

blogs
1 blog
twitter
16 X users
facebook
4 Facebook pages
wikipedia
1 Wikipedia page
googleplus
2 Google+ users
guideline
1 clinical guideline source

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Optimal step doses for drug provocation tests to prove beta‐lactam hypersensitivity
Published in
Allergy, November 2016
DOI 10.1111/all.13037
Pubmed ID
Authors
Abstract

Drug provocation tests (DPT) are commonly performed as part of ß-lactam allergy work-up, in case of negative skin tests, and in the absence of contraindications. The recommendations of learned societies have created a frame for DPT performance, but protocols vary widely between centres, generating various hypothesis-driven protocols (i.e., empirical dosing, driven by both safety concerns and practical aspects). The primary objective of this retrospective analysis was to detect eliciting dose thresholds (reactive doses) during ß-lactam DPT, using the survival analysis method, in order to suggest optimal step doses. Our secondary objective was to evaluate the safety of our 30-minute incremental one-day protocol. The study included all the patients explored in the Allergy Unit of the University Hospital of Montpellier (France), between September 1996 and July 2015 for a suspicion of drug hypersensitivity reaction to ß-lactams, with negative skin tests and positive DPT. During the study period, 182 positive DPT (accounting for 171 hypersensitive patients) were analysed. We identified eliciting thresholds and we suggest the following steps for DPT to ß-lactams: 5%-15%-30%-50% of daily therapeutic dose (with additional lower steps for index reactions of anaphylaxis). We confirm the safety of one-day protocol for immediate and mild non-immediate reactors, for both children and adults, with a surveillance period of 2h after the last administered dose, and a prolonged surveillance after discharge of 48 hours. This data-driven approach in designing DPT protocols is a step forward in improving DPT standardization, starting with the most frequently tested drugs, ß-lactam antibiotics. This article is protected by copyright. All rights reserved.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 10 14%
Student > Ph. D. Student 8 11%
Student > Master 7 10%
Researcher 4 5%
Professor > Associate Professor 4 5%
Other 12 16%
Unknown 28 38%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 31 42%
Immunology and Microbiology 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Chemistry 3 4%
Social Sciences 2 3%
Other 2 3%
Unknown 28 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2023.
All research outputs
#1,893,198
of 33,141,706 outputs
Outputs from Allergy
#773
of 7,474 outputs
Outputs of similar age
#28,296
of 441,649 outputs
Outputs of similar age from Allergy
#11
of 42 outputs
Altmetric has tracked 33,141,706 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,474 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,649 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.